Alan M. Garber
Publications
- Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. J Am Coll Cardiol. 2013; (12): 1250-8
- An economic analysis of conservative management versus active treatment for men with localized prostate cancer. J Natl Cancer Inst Monogr. 2012; (45): 250-7
- Cost-effectiveness of early colectomy with ileal pouch-anal anastamosis versus standard medical therapy in severe ulcerative colitis. Ann Surg. 2012; (1): 117-24
- Cost-effectiveness analysis of adjunct VSL#3 therapy versus standard medical therapy in pediatric ulcerative colitis. J Pediatr Gastroenterol Nutr. 2011; (5): 489-96
- Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med. 2011; (1): 1-11
- How CER could pay for itself--insights from vertebral fracture treatments. N Engl J Med. 2011; (15): 1390-3
- Individualized cost-effectiveness analysis. PLoS Med. 2011; (7): e1001058
- A cost-benefit analysis of preimplantation genetic diagnosis for carrier couples of cystic fibrosis. Fertil Steril. 2010; (6): 1793-804
- Correction to mikels et Al. (2010). J Exp Psychol Appl. 2010; (2): 157
- Cost effectiveness of alternative imaging strategies for the diagnosis of small-bowel Crohn's disease. Clin Gastroenterol Hepatol. 2010; (3): 261-7, 267.e1-4
- Following your heart or your head: focusing on emotions versus information differentially influences the decisions of younger and older adults. J Exp Psychol Appl. 2010; (1): 87-95
- Health outcomes and costs of community mitigation strategies for an influenza pandemic in the United States. Clin Infect Dis. 2010; (2): 165-74
- Incidental extracardiac findings at coronary CT: clinical and economic impact. AJR Am J Roentgenol. 2010; (6): 1531-8
- Modernizing device regulation. N Engl J Med. 2010; (13): 1161-3
- Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis. Ann Intern Med. 2010; (8): 481-7, W170-3
- The potential impact of comparative effectiveness research on U.S. health care expenditures. Demography. 2010: S173-90
- The role of costs in comparative effectiveness research. Health Aff (Millwood). 2010; (10): 1805-11
- Effectiveness and Cost-Effectiveness of Expanded Antiviral Prophylaxis and Adjuvanted Vaccination Strategies for an Influenza A (H5N1) Pandemic. Ann Intern Med. 2009
- Effectiveness and Cost-Effectiveness of Vaccination Against Pandemic Influenza (H1N1) 2009. Ann Intern Med. 2009
- Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic. Ann Intern Med. 2009; (12): 840-53
- Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009. Ann Intern Med. 2009; (12): 829-39
- Laparoscopy in women with unexplained infertility: a cost-effectiveness analysis. Fertil Steril. 2009; (2): 471-80
- The confirmatory trial in comparative-effectiveness research. N Engl J Med. 2009; (15): 1498-9
- Toward a 21st-century health care system: recommendations for health care reform. Ann Intern Med. 2009; (7): 493-5
- Is having more preapproval data the best way to assure drug safety? Health Aff (Millwood). 2008 Sep-Oct; (5): w371-3
- A menu without prices. Ann Intern Med. 2008; (12): 964-6
- Commentary: the impact of Medicare coverage policies on health care utilization. Health Serv Res. 2008; (4): 1302-7
- Future costs and the future of cost-effectiveness analysis. J Health Econ. 2008; (4): 819-21
- Is American health care uniquely inefficient? J Econ Perspect. 2008; (4): 27-50
- Management of acute kidney injury in the intensive care unit: a cost-effectiveness analysis of daily vs alternate-day hemodialysis. Arch Intern Med. 2008; (16): 1761-7
- Simple counts of ADL dependencies do not adequately reflect older adults' preferences toward states of functional impairment. J Clin Epidemiol. 2008; (12): 1261-70
- Systematic review: the effects of growth hormone on athletic performance. Ann Intern Med. 2008; (10): 747-58
- Unsupervised method for automatic construction of a disease dictionary from a large free text collection. AMIA Annu Symp Proc. 2008: 820-4
- The promise of health care cost containment. Health Aff (Millwood). 2007 Nov-Dec; (6): 1545-7
- A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer. J Clin Oncol. 2007; (6): 634-41
- B type natriuretic peptide testing was more cost effective than conventional diagnosis in patients with acute dyspnoea. Evid Based Med. 2007; (1): 28
- Extracting subject demographic information from abstracts of randomized clinical trial reports. Stud Health Technol Inform. 2007; (Pt 1): 550-4
- Rise of pay for performance: implications for care of people with chronic kidney disease. Clin J Am Soc Nephrol. 2007; (5): 1087-95
- Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med. 2007; (2): 104-15
- To use technology better. Health Aff (Millwood). 2006 Mar-Apr; (2): w51-3
- Combining text classification and Hidden Markov Modeling techniques for categorizing sentences in randomized clinical trial abstracts. AMIA Annu Symp Proc. 2006: 824-8
- Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA. 2006; (20): 2374-84
- The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis. Arch Intern Med. 2006; (11): 1209-17
- The effect of geriatrics evaluation and management on nursing home use and health care costs: results from a randomized trial. Med Care. 2006; (1): 91-5
- Invariance and inconsistency in utility ratings. Med Decis Making. 2005 Mar-Apr; (2): 158-67
- Evidence-based guidelines as a foundation for performance incentives. Health Aff (Millwood). 2005 Jan-Feb; (1): 174-9
- Multimedia quality of life assessment: advances with FLAIR. AMIA Annu Symp Proc. 2005: 694-8
- Cost-effectiveness and evidence evaluation as criteria for coverage policy. Health Aff (Millwood). 2004 Jan-Jun: W4-284-96
- Health plans' coverage determinations for technology-based interventions: the case of electrical bone growth stimulation. Am J Manag Care. 2004; (12): 957-62
- Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease. Am J Med. 2003; (5): 382-9
- Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest. Circulation. 2003; (3): 286-91
- Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction. Pediatrics. 2002; (3): 471-80
- Quality of life assessment software for computer-inexperienced older adults: multimedia utility elicitation for activities of daily living. Proc AMIA Symp. 2002: 295-9
- Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries, 1985 to 1995. Am Heart J. 2002; (3): 413-21
- Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995. Am Heart J. 2002; (3): 397-403
- Evidence-based coverage policy. Health Aff (Millwood). 2001 Sep-Oct; (5): 62-82
- Cost-effectiveness of automated external defibrillators on airlines. JAMA. 2001; (12): 1482-9
- A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease. Am J Gastroenterol. 2000; (2): 395-407
- Realistic rigor in cost-effectiveness methods. Med Decis Making. 1999 Oct-Dec; (4): 378-9; discussion 383-4
- Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Ann Intern Med. 1999; (9): 719-28
- Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. Ann Intern Med. 1999; (10): 789-99
- Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med. 1999; (10): 800-9
- The effect of search procedures on utility elicitations. Med Decis Making. 1998 Jan-Mar; (1): 76-83
- Cost-effectiveness and cost-benefit analysis of using methotrexate vs Goeckerman therapy for psoriasis. A pilot study. Arch Dermatol. 1998; (12): 1602-8
- Persistence of Medicare expenditures among elderly beneficiaries Frontiers in Health Policy Research I, MIT Press. 1998
- Cholesterol screening guidelines. Consensus, evidence, and common sense. Circulation. 1997; (6): 1642-5
- Cholesterol screening should be targeted. Am J Med. 1997; (2A): 26-30
- Economic foundations of cost-effectiveness analysis. J Health Econ. 1997; (1): 1-31
- Health care productivity. Brookings Papers on Economic Activity Microeconomics. 1997: 143-202,
- Measurement of the validity of utility elicitations performed by computerized interview. Med Care. 1997; (9): 915-20
- Mortality, hospital admissions, and medical costs of end-stage renal disease in the United States and Manitoba, Canada. Med Care. 1997; (7): 686-700
- Willingness-to-pay utility assessment: feasibility of use in normative patient decision support systems. Proc AMIA Annu Fall Symp. 1997: 223-7
- Cholesterol screening in asymptomatic adults, revisited. Part 2. Ann Intern Med. 1996; (5): 518-31
- Evaluating the federal role in financing health-related research. Proc Natl Acad Sci U S A. 1996; (23): 12717-24
- The cost of VA-sponsored research. Acad Med. 1996; (10): 1074-8
- Developing and testing a multimedia presentation of a health-state description. Med Decis Making. 1994 Oct-Dec; (4): 336-44
- Is high-flux dialysis cost-effective? Int J Technol Assess Health Care. 1993; (1): 85-96
- A multivariate analysis of mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol. 1992; (6): 1227-37
- Creating the costliest orphan. The Orphan Drug Act in the development of Ceredase. Int J Technol Assess Health Care. 1992; (4): 583-97
- Costs and benefits of prenatal screening for cystic fibrosis. Med Care. 1991; (5): 473-89
- Costs and health consequences of cholesterol screening for asymptomatic older Americans. Arch Intern Med. 1991; (6): 1089-95
- Practice guidelines and cholesterol policy. Health Aff (Millwood). 1991; (2): 52-66
- The new technology assessment. N Engl J Med. 1990; (10): 673-7
- A discrete-time model of the acquisition of antibiotic-resistant infections in hospitalized patients. Biometrics. 1989; (3): 797-816
- Screening asymptomatic adults for cardiac risk factors: the serum cholesterol level. Ann Intern Med. 1989; (8): 622-39
- The resting electrocardiogram as a screening test. A clinical analysis. Ann Intern Med. 1989; (6): 489-502
- The role of exercise testing in screening for coronary artery disease. Ann Intern Med. 1989; (6): 456-69
- Where to draw the line against cholesterol. Ann Intern Med. 1989; (8): 625-7
- Cost-containment and financing the long-term care of the elderly. J Am Geriatr Soc. 1988; (4): 355-61
- Antibiotic exposure and resistance in mixed bacterial populations. Theor Popul Biol. 1987; (3): 326-46
Help
Trial Administration